The Editors at Hepatitis Central
July 11, 2022

WHO publishes updated guidance on hepatitis C infection – with new recommendations on treatment of adolescents and children, simplified service delivery and diagnostics
Updated WHO Guidance on hepatitis C (HCV) infection was released today during a joint WHO-EASL-CDC symposium at the EASL International Liver Congress 2022 in London. These guidelines recommend a radical simplification of the care pathway to overcome barriers in access to HCV testing and treatment.
Continue reading this entire article:
https://www.who.int/news/item/24-06-2022-WHO-publishes-updated-guidance-on-hepatitis-C-infection

By Kristen Fuller, MD | Fact-checked by MDLinx Staff 
| Updated July 5, 2022

There’s a lot we don’t know about doctors who identify as LGBTQ.
LGBTQ is an acronym for lesbian, gay, bisexual, transgender and queer.

We don't know how many LGBTQ doctors there are, what specialties they're in, or where they practice.
As physicians, we’re often so focused on the inclusion of our LGBTQ patient population, but we’re behind in discussing LGBTQ medical students and physicians.
It’s time to have that discussion, and consider how we can better support our LGBTQ colleagues in the medical workplace.

The numbers
The Association of American Medical Colleges (AAMC) has only recently started to collect information pertaining to sexual orientation and gender identity from medical students.[1] Since 2016, the organization has included two sexual orientation and gender identity (SOGI) questions in its annual Matriculating Student Questionnaire and Medical School Graduation Questionnaire.
From 2017 to 2019, the percentage of graduating medical students identifying as bisexual increased from 4.2% to 5%, and those who identified as gay or lesbian increased from 3.6% to 3.8%.
TO CONTINUE READING:​ https://www.mdlinx.com/article/real-talk-the-challenges-of-being-an-lgbtq-doctor/3Qce6426b4MmPThCfmDhp?utm_campaign=Realtalk__070522

CORRESPONDENCE| VOLUME 7, ISSUE 7, P598-599, JULY 01, 2022PDF [71
Neil Gupta,Lindsey Hiebert,Paige A Armstrong,Carolyn Wester,John W Ward
Published:July, 2022DOI:https://doi.org/10.1016/S2468-1253(22)00168-6

Over a fifth of hepatitis C virus (HCV) infections occur in women of childbearing age.
 At least 19 countries, including the USA, have policies or guidelines recommending universal HCV screening during pregnancy.
2However, options for management and treatment of HCV infection during pregnancy are not well defined. Typical clinical practice is to refer and link pregnant individuals for treatment after pregnancy and the breastfeeding period; however, in practice, very few are successfully treated.
3Despite an excellent safety profile, direct-acting antivirals (DAAs) are not recommended for use in pregnancy. To date, only one prospective clinical trial has been published assessing HCV treatment in pregnancy.4

To Continue:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00168-6/fulltext​